Loading…
Chimera Biotec provides ultra-sensitive GLP/GCP bioanalytical support for drug development using its proprietary Immuno PCR technology, Imperacer®. The company specializes in developing and validating immunoassays with sub-pg/ml sensitivity for both regulated and discovery-phase research.
AI named Imperacer in November 2025.